Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × irofulven × Clear all

NCT00005070 2013-06-19

Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms